Cline Scientific
0,132 SEK +8,23%Vær den første som følger denne virksomhed
Cline Scientific develops cancer diagnostics and regenerative medicine treatments. The company is working with R&D through joint collaborations with pharmaceutical companies and academic researchers around the world. The patented surface nanotechnology is used in cell-based products and processes to drive projects within Life Science into and through the clinical phase. Cline operates out of Gothenburg, Sweden and was founded in 2012 from a long term research project in surface nanotechnology.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
CLINE B
Daglig lav / høj pris
0,122 / 0,167
SEK
Markedsværdi
5,96 mio. SEK
Aktieomsætning
7,71 t SEK
Volumen
48 t
Finanskalender
Generalforsamling
19.06.2024
Delårsrapport
23.08.2024
Årsrapport
21.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Patrik Sundh | 19,4 % | 38,6 % |
Formu Consulting AB | 5,2 % | 11,4 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Cline: StemCART updates on achieved milestones on the way to phase 1 study
Bokslutskommuniké for Cline Scientific AB (publ), 556867-8238, for the period 1 January - 31 December 2023
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools